Study | Study design | Sample size (HA/control) | Mean ages of patients (years) | Sex distribution (female/male) | Inclusion criteria |
---|---|---|---|---|---|
Camazzola et al. [28] | RCT | 61 (34/27) | 48.2 ± 9.0/50.4 ± 8.7 | 22/39 | Men younger than 60 years and women younger than 65 years having elective primary THA |
Dorr et al. [16] | Retrospective, matched pair | 30 (15/15) | 55 (38–71) | 10/5 | Patients who underwent bilateral primary THA |
Hamadouche et al. [34] | RCT | 45 (22/23) | 65/64 | 41/39 | Patients with osteoarthritis of the hip requiring THA |
Incavo et al. [32] | RCT | 50 (24/26) | 55 | NR | Patients who underwent THA |
Kim et al. [23] | RCT | 100 (50/50) | 45.3 (27–61) | 14/36 | Patients who underwent sequential bilateral primary THA |
Kim et al. [24] | RCT | 110 (55/55) | 46.3 (27–63) | 39/16 | Patients who underwent bilateral primary THA |
Lee and Lee 2007 [33] | RCT | 40 (20/20) | 44 (25–72) | 2/18 | Patients who had late-stage bilateral osteonecrosis were randomly treated with bilateral THA |
Lombardi Jr. et al. [12] | Retrospective, observational study | 131 (46/85) | 52 (29–72)/51 (22–78) | 67/97 | Patients who underwent THA using a MHP |
Mcpherson et al. [36] | Retrospective, matched pair | 84 (42/42) | 55 ± 11.4/56.5 ± 11.7 | 36/48 | Patients of the same gender, bone type, activity level, and diagnosis, ages within 5 years, weight within 25 pounds, Charnley activity class |
Parvizi et al. [9] | Prospective, matched-pair | 86 (43/43) | 66.8 ± 6.2/65.7 ± 5.9 | NR | The patients matched for age, sex, weight, diagnosis, Charnley class, operative approach, bone quality, femoral head size, type of acetabular component, and duration of follow-up |
Paulsen et al. [38] | Retrospective comparison | 3,158/4,749 | NR | 3,834/4,073 | Patients underwent primary uncemented THA, who were younger than 70 years of age at surgery |
Ranawat et al. [35] | RCT | 174 (92/82) | 54.9 (29.4–67.5)/55.5 (28.6–71.8) | 38/114 | Patients received cementless THA with the Ranawat-Burstein metaphyseal-diaphyseal fit hip system |
Rothman et al. [10] | Retrospective, matched pair | 104 (52/52) | 64 (31.2–86.1) | 49/49 | Consecutive THA with use of Taperloc stem, matched for age, sex, weight, diagnosis, Charnley class, operative approach, and duration of follow-up |
Sanchez-Sotelo et al. [37] | Retrospective, matched-pair | 136 (68/68) | 54 (23–66)/56 (22–67) | 56/80 | Patients who had a primary hip replacement with insertion of either a porous-coated or HA-coated Omniflex femoral componene |
Sano et al. [39] | Retrospective, observational study | 55 (24/31) | 64.0 (51–83)/62.7 (41–80) | 49/3 | Patients in whom surgery was performed at least 2 years before the present study |
Santori et al. [14] | Retrospective, observational study | 227 (158/69) | NR | NR | Patients underwent THA with the anatomic prosthesis |
Søballe et al. [4] | RCT | 26 (14/12) | 56.8 (48–63)/58.6 (50–68) | NR | Patients who underwent THR to receive prosthetic with either Ti-alloy coating or HA coating |
Tanzer et al. [22] | RCT | 39 (17/22) | 66 (54–80)/64 (43–78) | 13/26 | Patients undergoing a cementless THA |
Tanzer et al. [31] | RCT | 318 (164/154) | 64.5 ± 9.9/63.1 ± 10.5 | 153/165 | All patients who underwent cementless THA |
Yee et al. [30] | RCT | 62 (35/27) | 48.2 ± 9.0/50.4 ± 8.7 | 11/22 | Men younger than 60 years of age and women younger than 65 years of age undergoing primary THA |
Yoon et al. [29] | RCT | 75 (37/38) | 45.3 (20–69)/46.0 (23–71) | 14/49 | Patients who underwent THA use a multilock femoral stem with or without HA/TCP coating |